BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed MANE catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:6e4c98f311b796212273@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:MANE P3 readout (est.): Safety and Efficacy of VDPHL01 in Males Wit
 h AGA
DESCRIPTION:Safety and Efficacy of VDPHL01 in Males With AGA\nNCT06972264 |
  PHASE3 | ACTIVE_NOT_RECRUITING | sponsor: Veradermics\, Inc.\nPrimary com
 pletion date (ESTIMATED)\; top-line results usually follow later.\nDate pr
 ecision: month (shown on the first day)\nTicker MANE (confidence 0.9)\nSou
 rce: https://clinicaltrials.gov/study/NCT06972264\nScheduling/reference da
 ta from public records\; dates can move. Not investment\, legal or medical
  advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06972264
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
